Please Note: This trial is no longer enrolling new participants
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
| Protocol No. | CTO-CFT7455-2101 | Scope | National |
|---|---|---|---|
| Principal Investigator | Attaya Suvannasankha | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
